- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05010135
Evaluation of Balance and Gait Weight Distribution in Patients With Vertebral Column Fractures
Vertebral column fracture presents a significant warning of subsequent osteoporotic fracture and frequent falls. The presence of an osteoporotic vertebral fracture is also a predictor of further risk of vertebral and other osteoporotic fractures. This study provides balance assessment and gait evaluation for subjects with a known vertebral fracture.
Subjects are the known cases of vertebral fracture living in the community. They will be assessed for their balance and gait weight distribution by the TechnoBody for their balance ability, and the Zebris Gait System for the gait weight distribution. The Humac Norm for the lower limb muscle strength.
Study Overview
Status
Conditions
Detailed Description
This study evaluates the balance and weight distribution in walking gait in subjects with vertebral column fracture, comparing with the healthy subjects.
Study Objectives:
- To evaluate the balance and gait weight distribution of the vertebral fracture patients.
- To analyze the association between balance and gait weight distribution with fall risks in patients with stable vertebral fractures.
- To construct a community fall prevention protocol.
Methodology:
Subjects:80 ambulatory subjects with a history of vertebral fracture, aged 60 and above, will be recruited from the community.
Study Design: an observational study by convenient sampling design.
Sample size calculation:
The calculated sample size of vertebral column fractures is 64. Allowing a 20% dropout rate, the round-up figure is 80.
Assessments will include the following:
- . A questionnaire to collect the following information: i. Subjects' demographics, medical and medication history, and fall history. ii. Numeric Pain Rating Scale; ii. Roland-Morris Disability Questionnaire; iii. Oswestry Disability Index (Chinese version); iv. SF-12;
- A 6-meters Up and Go test;
- Hand Grip Strength to evaluate the muscle strength of the subjects
- Flexibility measurement (how far to lean forward);
- Balance and Centre of Gravity evaluation by the TechnoBody Machine;
- . Zebris Gait System for their gait weight distribution evaluation, and
- Humac Norm for the Quadriceps and Hamstrings muscle strength (both sides).
Statistical Analysis:
- Statistical analyses will be performed using SPSS (version 24).
- Two-sided tests and an α-level of 5% were used as the level of significance.
- Chi-square tests were used for categorical variables.
- Two-sample independent t-tests were used for continuous variables.
The balance, gait weight distribution pattern, and muscle strength will be analyzed by ANOVA.
Correlation analysis will be conducted for the factors of gender, age, and comorbid conditions.
From the results, strategies for fall prevention will be modelled and formulated.
Inclusion Criteria:
- All subjects are aged 60 or above with a history of vertebral fracture, and able to walk without assistance;
- Not received a bilateral hip replacement and spinal surgery;
- No known malignance at time of enrollment;
- Able to attend Tung Wah College for examination and assessment, understand, and sign the consent form.
Exclusion criteria:
- Unable to attend the research center for receiving examination and tests;
- Unable to give consent;
- Diseases such as stroke and Parkinson's Disease that adversely affect the balance and gait weight distribution;
- Bed-bound or wheel-chair bound patients.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Anthony WL Kwok, Ph.D
- Phone Number: +85296336734
- Email: anthonykwok@twc.edu.hk
Study Contact Backup
- Name: Grace PY Szeto, Ph.D
- Phone Number: +8523468 6721
- Email: graceszeto@twc.edu.hk
Study Locations
-
-
-
Kowloon, Hong Kong, 0000
- Recruiting
- Anthony Kwok
-
Contact:
- Anthony WL Kwok, Ph.D
- Phone Number: 96336734
- Email: anthonykwok@twc.edu.hk
-
Contact:
- Grace PY Szeto, Ph.D
- Phone Number: 34686670
- Email: Graceszeto@twc.edu.hk
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
All subjects are aged 60 or above with a history of vertebral fracture, and able to walk without assistance for vertebral fracture subjects.
All subjects are aged 60 or above with no history of vertebral fracture, and able to walk without assistance for the healthy subjects.
Description
Inclusion Criteria:
- All subjects are aged 60 or above with a history of vertebral fracture, and able to walk without assistance;
- Not received bilateral hip replacement and spinal surgery;
- No known malignance at time of enrollment;
- Able to attend Tung Wah College for examination and assessment, understand and sign the consent form.
Exclusion Criteria:
- Unable to attend the research center for receiving examination and tests;
- Unable to give consent;
- Diseases such as stroke and Parkinson's Disease that adversely affect the balance and gait weight distribution;
- Bed bound or wheel-chair bound patients.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Healthy Subject
Aged 60 and over.
Male or Female.
Able to give consent, and attend the assessment centre for the balance and gait weight distribution assessment.
|
To measure the above parameters and to compare between the healthy subjects and the vertebral fracture subjects
Other Names:
|
Vertebral fracture subjects
Aged 60 or over. Male or Female. Able to give consent, and attend the assessment centre for the balance and gait weight distribution assessment. Have been diagnosed by doctors to have the vertebral fracture |
To measure the above parameters and to compare between the healthy subjects and the vertebral fracture subjects
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Balance (measure by the TechnoBody machine to show the amplitude of body displacement from the centre)
Time Frame: Up to 24 weeks
|
compare between the 2 groups
|
Up to 24 weeks
|
Gait weight distribution (measure by the Zebris Rehabwalk machine to show the force in Newton)
Time Frame: Up to 24 weeks
|
compare between the 2 groups
|
Up to 24 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Muscle strength (measure by the Humac Norm machine to evaluate the Quadriceps and Hamstrings strength in Peak Torque, N)
Time Frame: Up to 24 weeks
|
Compare between the 2 groups
|
Up to 24 weeks
|
Positional senses (measure by the position sensor attached on the feet, legs, thighs, lumber spine, thoracic spine and the cervical spine to show the body displacement in angle degrees).
Time Frame: Up to 24 weeks
|
Compare between the 2 groups
|
Up to 24 weeks
|
Low Back Pain (measure by the Oswestry Disability Index and Roland Morris Disability Questionnaire)
Time Frame: Up to 24 weeks
|
Compare between the 2 groups
|
Up to 24 weeks
|
Quality of Life evaluation (measure by the SF-12 questionnaire)
Time Frame: Up to 24 weeks
|
Compare between 2 groups
|
Up to 24 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Anthony WL Kwok, Ph.D, Tung Wah College
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- TungWC
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vertebral Fracture
-
AgNovos Healthcare, LLCRecruitingVertebral Fracture | Vertebral Compression Fracture | Vertebral CompressionGermany, Spain
-
AgNovos Healthcare, LLCRecruitingVertebral Compression Fracture | Vertebral Compression | Compression FractureUnited States
-
University of Texas Southwestern Medical CenterMedtronicCompletedLumbar Vertebral FractureUnited States
-
Optimus Clinical ResearchCareFusionCompletedVertebral Compression Fractures | Osteoporotic Vertebral Compression Fractures | Acute Vertebral FracturesAustralia
-
University Hospital, Clermont-FerrandCompletedVertebrOpLasty Versus Conservative Treatment in Acute Non Osteoporotic Vertebral Fractures (VOLCANO)Vertebral Compression Fracture | Spinal TraumaFrance
-
Icahn School of Medicine at Mount SinaiRecruitingVertebral Compression Fractures | Osteoporotic Vertebral Compression FracturesUnited States
-
Jaseng Medical FoundationRecruitingVertebral Compression Fracture | Vertebral Compression | Korean Traditional Medicine | Integrative Korean MedicineKorea, Republic of
-
Hospital for Special Surgery, New YorkCompletedVertebral Compression FractureUnited States
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingPrediction Model | Osteoporotic Vertebral FractureChina
-
Northwell HealthCompletedVertebral Fracture | Vertebral Compression | Vertebra Compression FractureUnited States